Entera Bio (ENTX) Operating Leases (2020 - 2026)
Entera Bio (ENTX) recorded quarterly Operating Leases of $263000.0 in Q1 2026, up 1.15% on a QoQ basis from $260000.0 in Q4 2025, and up 415.69% year-over-year from $51000.0 in Q1 2025.
Entera Bio (ENTX) Operating Leases (2020 - 2026) Analysis & Trends
Entera Bio has disclosed Operating Leases across 7 years of filings, most recently posting $263000.0 for Q1 2026.
- Quarterly Operating Leases rose 415.69% year-over-year to $263000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $263000.0 (up 415.69% YoY) and the FY2025 annual result came in at $260000.0, down 4.41% from the prior year.
- Operating Leases improved to $263000.0 in Q1 2026, from $260000.0 in the prior quarter.
- Over five years, Operating Leases peaked at $456000.0 in Q2 2023 and troughed at $3000.0 in Q3 2022.
- A 5-year average of $186666.7 and a median of $179000.0 in 2024 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2023 — Operating Leases surged 13300.0% — and 2025, when it sank 94.97%.
- Tracing ENTX's Operating Leases over 5 years: stood at $3000.0 in 2022, then surged by 12900.0% to $390000.0 in 2023, then sank by 30.26% to $272000.0 in 2024, then fell by 4.41% to $260000.0 in 2025, then increased by 1.15% to $263000.0 in 2026.
- Business Quant data shows ENTX's Operating Leases at $263000.0 in Q1 2026, $260000.0 in Q4 2025, and $41000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Entera Bio | 56.59 Mn | 52.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 263,000.00 |
| Dec 31, 2025 | 260,000.00 |
| Sep 30, 2025 | 41,000.00 |
| Jun 30, 2025 | 9,000.00 |
| Mar 31, 2025 | 51,000.00 |
| Dec 31, 2024 | 272,000.00 |
| Sep 30, 2024 | 147,000.00 |
| Jun 30, 2024 | 179,000.00 |
| Mar 31, 2024 | 224,000.00 |
| Dec 31, 2023 | 390,000.00 |
| Sep 30, 2023 | 402,000.00 |
| Jun 30, 2023 | 456,000.00 |
| Sep 30, 2022 | 3,000.00 |
| Jun 30, 2022 | 5,000.00 |
| Mar 31, 2022 | 98,000.00 |
| Dec 31, 2021 | 302,000.00 |
| Dec 31, 2020 | 432,000.00 |